SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #97CAS 1区Top JournalHybrid

Lancet Oncology

Abbreviation (ISO):LANCET ONCOL
Country: United States•WoS SCIE Quartile: Q1•Scopus SJR: 9.432•SCImago Rank: #97•Identifier (ISSN):1470-2045(Print)/1474-5488(Online)•Articles / Year: 164•Estimated Publication Fee (APC): $5,213 USD
Clarivate IF (2026)Q1
33.7
↓ -2.2

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
274

274 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
164articles/year
16.03% Gold OA•80% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 33.7)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 33.7)
🔵 Computed
20253.00đ
WoS Q1 có IF ≥ 5.0(IF: 35.9)
🔵 Computed
20243.00đ
WoS Q1 có IF ≥ 5.0(IF: 41.6)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 51.1)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 54.433)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 41.316)
🔵 Computed
20203.00đ
WoS Q1 có IF ≥ 5.0(IF: 33.752)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. All papers should be written to be clearly understandable to the journal’s readers in a wide range of specialties and countries.

Topics Covered (Recognized by AI)
Medicine95.3%Biology87.4%Internal medicine71.3%Genetics63.1%Chemistry52.7%Cancer49.6%Biochemistry48.2%Oncology46.7%Political science41.6%Law41.4%Pathology40.1%MEDLINE35.1%Surgery33.8%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #97Scopus Q1SCImago Profile
Scopus Coverage:2000-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
9.432

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
455

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
9.41

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$5,213 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations13,495
3-Year Documents1,333
Citable Documents637

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate41.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Lancet Publishing Group
Publication Language
English
Frequency
Monthly
Founding Year
2000
Editorial Address
ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRSCIE
9/333Q1
ONCOLOGY
JCISCIE
6/333Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—307511
202535.95034,939
202441.647010,226
202351.142015,835
202254.43349822,600
202141.31649945,368
202033.75249661,056
2019—56058,754
2018—57454,880
2017—64071,352
2016—62473,359
2015—66178,775
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Lancet Oncology

WoS Q1
2336496320202021202220232024202535.90
Annual Impact Factor Metric
2025:35.9

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

98% MatchExplore →
Jama Oncology
IF: 23.9Q1
97% MatchExplore →
Jama Oncology
IF: 23.9Q1
97% MatchExplore →
Record UUID: 7ab1b842-2342-4628-9a75-7fead9698118
Database Updated: 2026-10-01